CRISCuris, Inc.

$15M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-1.4% YoY

Gross Profit

$10M97.9% margin

Operating Income

-$48M-482.2% margin

Net Income

-$47M-473.0% margin

EPS (Diluted)

$-8.96

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$77M

Total Liabilities

$58M

Stockholders' Equity

$20M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$10M	-1.4%
Gross Profit	$10M	$10M	-0.9%
Operating Income	-$48M	-$53M	+8.8%
Net Income	-$47M	-$57M	+16.3%

CRIS FY 2023 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena